SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-165553
Filing Date
2023-06-13
Accepted
2023-06-12 21:44:57
Documents
1
Group Members
ALEX VIEUXEXPLORER PARENT LLCFOUNDER HOLDINGS LLCSTEVEN FLETCHER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d485444dsc13da.htm SC 13D/A 144890
  Complete submission text file 0001193125-23-165553.txt   146539
Mailing Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016
Business Address 260 MADISON AVENUE, SUITE 800 NEW YORK NY 10016 2122874092
BioPlus Acquisition Corp. (Subject) CIK: 0001856653 (see all company filings)

IRS No.: 981583272 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93123 | Film No.: 231010112
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 544 AIRPORT BOULEVARD SUITE 400 BURLINGAME CA 94010
Business Address 544 AIRPORT BOULEVARD SUITE 400 BURLINGAME CA 94010 (415) 518-6725
BioPlus Sponsor LLC (Filed by) CIK: 0001895859 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A